Biogen Idec, Abbott release Select Phase 2b RRMS drug trial results
Biogen Idec and Abbott have released top-line results from a double-blind, dose-ranging, randomized and placebo-controlled...
Innovacyn introduces eye, ear formulations
Innovacyn, a provider of human and animal healthcare products, has added Vetericyn VF Ophthalmic Wash...
Glenmark settles patent case with Daiichi, Genzyme
Glenmark Pharmaceuticals has settled patent litigation suit with Daiichi Sankyo and Genzyme in relation to...
RxMD signs drug development agreement with GlycoRegImmune
RxMD has collaborated with GlycoRegImmune (GRI) to develop new treatments by using GRI's novel natural...
Evotec, Roche collaborate to develop oncology biomarkers
Evotec has entered into an oncology research and development agreement with Roche to organize multiple...
Evotec and PsychoGenics Enter into a Strategic Alliance to Provide Integrated CNS Drug Discovery...
Evotec AG announced that it has entered into a strategic alliance with PsychoGenics Inc. to...
Radius, 3M Drug Delivery Systems Sign Development Agreement for Transdermal Drug Delivery of BA058
Radius Health, Inc. and 3M Drug Delivery Systems announced an agreement to collaborate on the...
Phase 3 Data Demonstrate XGEVA(TM) (Denosumab) is First Bone Targeted Therapy to Prevent Spread...
Amgen announced primary results of a pivotal Phase 3 trial ('147) demonstrating that XGEVA(TM) (denosumab)...
Utilising a CTMS to Create a Development Edge
As clinical trials become more globalised and complex, there is an increased need for investigators...
InhibOx and COSMIC Discoveries align to deliver full service drug discovery offering
New service supports big pharma’s drive to outsourcing by offering highly sophisticated technologies for drug...